Randomized study of evolocumab in patients with type 2 diabetes and dyslipidaemia on background statin: Pre‐specified analysis of the Chinese population from the BERSON clinical trial-Reference-Cited by-同舟云学术

Randomized study of evolocumab in patients with type 2 diabetes and dyslipidaemia on background statin: Pre‐specified analysis of the Chinese population from the BERSON clinical trial

Published:2019-04-14 Issue:6 Volume:21 Page:1464-1473
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Chen Yundai¹,Yuan Zuyi²,Lu Juming³,Eliaschewitz Freddy G.⁴,Lorenzatti Alberto J.⁵^ORCID,Monsalvo Maria Laura⁶,Wang Nan⁶,Hamer Andrew W.⁶,Ge Junbo⁷

Affiliation:

1. Department of CardiologyChinese People's Liberation Army General Hospital Beijing China

2. First Affiliated Hospital of Xi'an Jiaotong University Shaanxi China

3. Department of EndocrinologyChinese People's Liberation Army General Hospital Beijing China

4. CPCLIN/DASA ‐ Centro de Pesquisas Clínicas São Paulo Brazil

5. Clinical Research and Cardiology, Instituto Medico DAMIC / Fundación Rusculleda Córdoba Argentina

6. Clinical Development, Amgen Inc. Thousand Oaks California

7. Department of Cardiology, Shanghai Institute of Cardiovascular DiseasesZhongshan Hospital, Fudan University Shanghai China

Funder

Amgen

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.13700

Reference47 articles.

1. Prevalence and Ethnic Pattern of Diabetes and Prediabetes in China in 2013

2. Risks and Population Burden of Cardiovascular Diseases Associated with Diabetes in China: A Prospective Study of 0.5 Million Adults

3. Association Between Diabetes and Cause-Specific Mortality in Rural and Urban Areas of China

4. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How safe are proprotein convertase subtilisinekexin type 9 inhibitors in diabetes?;Current Opinion in Lipidology;2024-03-20

2. New Advances in Lipid Interventions under Stratified Management of Atherosclerotic Cardiovascular Disease;Advances in Clinical Medicine;2024

3. Methodology and results of cost-effectiveness of LDL-C lowering with evolocumab in patients with acute myocardial infarction in China;Cost Effectiveness and Resource Allocation;2023-12-01

4. Sex Differences in Cardiovascular Outcomes and Cholesterol-Lowering Efficacy of PCSK9 Inhibitors;JACC: Advances;2023-11

5. Protective effect of evolocumab on Müller cells in the rat retina under hyperglycaemic and hypoxic conditions;Journal of Diabetes and its Complications;2023-10